Two drug candidates, TRAP-netrinDCC and TRAP-netrinUNC5A, which are Fc-fused and stabilized ectodomains of respectively DCC or UNC5A, have been shown to trigger death of netrin-1 expressing tumour cells in vitro and tumour growth inhibition in engrafted mice models (not shown). This evidence concerns the gene NTN1 and neoplasm.